Oct 25 2024 This Week in Cardiology

Oct 25 2024 This Week in Cardiology

‏التالي

Jun 19 2026 This Week in Cardiology

Listener feedback, more long-term data on the TAVR/SAVR question, population prevalence of valvular heart disease in the US, and a CMS proposal to expand TAVR coverage are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthcare prof ...  عرض المزيد

Jun 12 2026 This Week in Cardiology

Listener feedback, transcatheter tricuspid valve replacement, a new metabolic disease called CKM, the ARISE-FLUIDS Trial, the BIHCA trial, and temporal trends in ICD therapies are the topics John Mandrola, MD, discusses in this week's podcast. This podcast is intended for healthc ...  عرض المزيد

‏حلقات موصى بها

Episode 072: Introduction to Diffuse Large B-Cell Lymphoma (DLBCL)
The Fellow on Call: The Heme/Onc Podcast

This week, we kick off a new series focusing on diffuse large B-cell lymphoma. In this first episode, we discuss the basics that everyone needs to understand before diving into the management of this disease.

<p class="" style="white- ...  عرض المزيد

Episode 139: Follicular Lymphoma Series, Pt 4 - Relapsed/Refractory Management (Cellular therapy options)
The Fellow on Call: The Heme/Onc Podcast

This week, we continue talking about relapsed/refractory follicular lymphoma, this time focusing on cellular therapy options, namely bispecific agents and CAR T therapy. If you have not done so, we h ...

  عرض المزيد

Episode 116: AML Series, Pt. 2 - MDS/AML Diagnosis and Risk Stratification
The Fellow on Call: The Heme/Onc Podcast

In this week’s episode, we discuss the diagnostic criteria and risk stratification for myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), building on our discussion from last week. Also, if you have not done so, please do check out our hemepath series to ensure y ...

  عرض المزيد

Episode 137: Follicular Lymphoma Series, Pt 2. - Front-line Management
The Fellow on Call: The Heme/Onc Podcast

This week, we continue our conversation on follicular lymphoma, this time focusing on front line therapy. We discuss how we approach localized and diffuse disease and the data behind why we do what we do. </ ...

  عرض المزيد